Clay Siegall Is Creating Solutions For Cancer Patients
Dr. Clay Siegall has been working for years to try to create effective cancer treatments for individuals that are not responding well to other methods of treatment. He is the CEO of Seattle Genetics. Seattle Genetics is the largest cancer treatment production facility in the Northwest. So far Seattle Genetics has proven that they are one of the fastest growing companies in the market. Their stock prices have tripled in just the last five years.
In addition to serving as the CEO of Seattle Genetics, Dr. Clay Siegall also serves as the Chairman of the Board. He has held the title of CEO since 2002 but the company was founded in 1998. His company has been successful in developing cutting edge cancer therapy drugs and has more in the works.
Dr. Clay Siegall attended George Washington University where he obtained his Ph.D. He worked with prestigious pharmaceutical companies such as Bristol-Myers Squibb and the National Cancer Institute. The biggest accomplishment that Seattle Genetics has had with therapy drugs is Adcetris. Adcetris was approved in 2011 and is currently available in over sixty countries worldwide.
Dr. Clay Siegall has a passion for creating effective cancer treatments that can help patients when other treatments are ineffective. He combines his keen sense of business with his in-depth scientific knowledge to propel the company to new heights. He has a unique combination of talents that allow him to be highly successful and create good business strategies for Seattle Genetics. He has been able to raise over $1.2 billion from both public and private companies to help further fund research and development.